Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids.

There may be increased naloxone episodes among patients receiving opioids and gabapentinoids. Future studies are needed to evaluate the incremental risk of respiratory depression and oversedation as it pertains to concomitant medication administration and patient-specific factors.